Sunstar Joint Stock Company   Report issue

For profit Phase 2 Phase 3
Founded: Hanoi Vietnam (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2017
NCT03845959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Sunstar Joint Stock Company

Active Ingredients

Drugs in Phase 3 Trials (1)

ketoconazole (nizoral) (1 trial)

Drugs in Phase 2 Trials (2)

td0019 (1 trial)

TD0069 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3